Feb. 27 at 5:36 PM
$CHE drops 15% post-earnings — what’s the downturn about? 📉
Chemed's Q4 adjusted EPS of
$6.42 missed the Zacks Consensus Estimate by 8.55%, with revenues also falling short by 2.55%. VITAS saw revenue growth, while Roto-Rooter faced a decline, alongside margin contraction.
Full insights here 👉 https://www.zacks.com/stock/news/2877001/che-stock-falls-post-q4-earnings-revenue-miss-margins-crash?cid=sm-stocktwits-2-2877001-body-35587&ADID=SYND_STOCKTWITS_TWEET_2_2877001_BODY_35587